HomeINNO • CNSX
add
Innocan Pharma Corp
Previous close
$0.17
Day range
$0.17 - $0.17
Year range
$0.15 - $0.33
Market cap
47.36M CAD
Avg Volume
22.24K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 5.40M | 10.38% |
Operating expense | 5.33M | 2.80% |
Net income | -114.00K | 87.09% |
Net profit margin | -2.11 | 88.31% |
Earnings per share | — | — |
EBITDA | -913.00K | -3.05% |
Effective tax rate | 1,700.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.01M | 28.91% |
Total assets | 9.26M | 33.43% |
Total liabilities | 2.24M | -12.37% |
Total equity | 7.02M | — |
Shares outstanding | 291.23M | — |
Price to book | 8.50 | — |
Return on assets | -24.37% | — |
Return on capital | -32.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -114.00K | 87.09% |
Cash from operations | -504.00K | 61.56% |
Cash from investing | 65.00K | 822.22% |
Cash from financing | 400.00K | -64.22% |
Net change in cash | -49.00K | 64.75% |
Free cash flow | -460.25K | 8.27% |
About
Founded
2018
Website
Employees
8
